✦ LIBER ✦

IL-2 induced immunocompetence in HIV/HCV or HIV/HBV coinfected patients under antiretroviral therapy

✍ Scribed by A. Barreiros; J. Schlaak; C. Schramm; E. Bayer; P. Galle; H. Jaeger; H. Loehr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral therapy in the HCV-coinfected

✍ James S. Park; Neeraj Saraf; Douglas T. Dieterich 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 426 KB

1066 ACCELERATED FIBROSIS PROGRESSION IN

✍ Macías, J.; von Wichmann, M.A.; Rivero, A.; Téllez, F.; Merino, D.; Márquez, M.; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Influence of HCV or HBV coinfection on a

✍ The French Network of Pharmacovigilance Centres; Emmanuelle Guitton; Jean-Louis 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 104 KB

HCV E2 genomic variability in HCV-HIV-co

✍ D. Neau; E. Legrand; P. Trimoulet; A.C. Jouvencel; M. Dupon; J.M. Ragnaud; M.E. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Low-dose, non-toxic IL-2 therapy is effe

✍ Schlaak, J.F.; Radecke, K.; Meyer zum Büschenfelde, K.-H.; Gerken, G. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 169 KB

556 Mutations in the NS3 protease domain

✍ S. Bagaglio; R. Bruno; C. Lodrini; A. Lazzarin; F. Canducci; G. Morsica 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB